Key result
Non-rheumatic degenerative mitral valve disease death rates fell annually as global cases hit ~15.5 million.
Why the study?
Non-rheumatic degenerative mitral valve disease (NDMVD) is an emerging global health challenge affecting older adults, and updated insights into its trends are needed to inform policy and resource planning as populations age.
Observational (n=15,494,647)
Yes
Despite declining age-standardized mortality and DALY rates for non-rheumatic degenerative mitral valve disease between 1990 and 2021, the absolute global burden of cases, deaths, and DALYs continues to rise due to population growth and aging, particularly affecting adults aged 70 and older in high-SDI regions.
Answers are grounded in this paper and cite their sources.
Updated NDMVD burden estimates inform resource planning; leaves open causal drivers and targeted interventions.
Non-rheumatic degenerative mitral valve disease (NDMVD) is an emerging global health challenge, particularly affecting older adults. As populations age, updated insights into NDMVD trends are essential to inform policy and resource planning. We analyzed data from the Global Burden of Disease Study 2021 to assess the prevalence, incidence, deaths, and disability-adjusted life years (DALYs) related to NDMVD from 1990 to 2021. Age-standardized rates (ASRs) were calculated at global, regional, and national levels, with further stratification by age, sex, and sociodemographic index (SDI). In 2021, an estimated 15,494,647 (95% UI = 14457324–16702738) prevalent cases were living with NDMVD globally, 1,162,558 (1084357–1244874) incident cases, 36843.45 (95% UI = 31883.55-41571.63) deaths, and 943,258 (95% UI = 818239.2-1134001) DALYs globally. From 1990 to 2021, the global ASPR showed a small but statistically significant decrease (EAPC=-0.095, 95% CI, -0.135 to -0.055), whereas the global ASIR remained statistically stable (EAPC=-0.025, 95% CI=-0.075 to 0.026). The ASDR and age-standardized DALY rate decreased significantly, with EAPCs of -1.490 (95% CI, -1.601 to -1.379) and − 1.317 (95% CI, -1.414 to -1.219), respectively. Older adults (≥ 70+) and populations in high-SDI regions experienced a substantial NDMVD burden with higher number of prevalent cases, incident cases, deaths cases, and DALYs cases. Males generally had higher ASPRs and ASIRs, whereas females exhibited higher ASDRs in many regions. From 1990 to 2021, the global ASPR showed a small but statistically significant decrease, the ASIR remained statistically stable, and both the ASDR and age-standardized DALY rate declined significantly. Nevertheless, the absolute numbers of prevalent cases, incident cases, deaths, and DALYs continued to increase, highlighting the growing absolute burden of NDMVD in the context of population growth and aging.
No takes yet. Share an insight, caveat, or question.
陈丽萍 et al. (2026) conducted an observational in Non-rheumatic degenerative mitral valve disease (n=15,494,647). Non-rheumatic degenerative mitral valve disease temporal trends (1990-2021) was evaluated on Age-standardized prevalence, incidence, death, and disability-adjusted life year (DALY) rates (EAPC -0.095 for ASPR, 95% CI -0.135 to -0.055). Non-rheumatic degenerative mitral valve disease age-standardized death rates decreased from 1990-2021, reaching 15.49 million cases in 2021.
Synapse has enriched 10 related papers. Consider them for comparative context: